MedTrace Logo

The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa

NCT01741805 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-07-29

No results posted yet for this study

Summary

Asthma is a chronic illness characterized by inflammation of the airways. Severe asthma is defined in the literature as asthma not controlled by medication. In recent years it has become known that severe asthma is a variable disease and has subtypes relating to the age of onset, type of inflammation and allergy, obesity, etc.

Our aim is to characterize the phenotypes of severe asthma population in our clinic and compare the prevalent phenotypes to the phenotypes described before.

Conditions

Interventions

OTHER

Severe Asthma

Demographic data, Spirometry, induced sputum, IgE, Aspergillus specific IgE

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Michal Shteinberg, MD,PhD · Pulmonology Institute, Carmel Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-11-30
Completion
2014-04-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741805 on ClinicalTrials.gov